TP53 and breast carcinoma: Additionally, it was found that anti-miR-191-5p treatment sensitized breast cancer cells towards apoptosis induced by the drug doxorubicin by increasing p53, suggesting the clinical potential of breast cancer therapeutics targeting this miRNA [114].